methods for staging beta amyloid pathology, for treating Alzheimer's disease, for evaluating the effects of experimental ad therapy, and for determining the inclusion of individuals in a clinical trial.

摘要

The present invention relates to an in vivo imaging method and, in particular, to a method for the evaluation of in vivo beta amyloid (α) distribution images in the brain of an individual suspected of having Alzheimer's disease (AD). ). The method of the present invention provides more detailed information to the clinician compared to prior art methods, facilitating the identification of individuals who will benefit most from disease-modifying therapies.